HEALTH

J&J recalls lots of Infants’ Mylicon Gas Relief Dye Free

BY Michael Johnsen

FORT WASHINGTON, Pa. Johnson & Johnson-Merck Consumer Pharmaceuticals Company Monday evening voluntarily recalled approximately 12,000 units of Infants’ Mylicon Gas Relief Dye Free (simethicone-antigas) non-staining sold in 1-ounce plastic bottles that were distributed after Oct. 5 because some of the bottles could include metal fragments that were generated during the manufacturing process.

Although the potential for serious medical events is low, the company is implementing this recall to the consumer level as a precaution. If any medical events were to occur, most are expected to be temporary and resolve without medical treatment. Parents who have given the product to their infant and are concerned should contact their health care provider immediately.

The company is taking this action in consultation with the Food and Drug Administration, J&J reported.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Robitussin Cough & Chest Congestion DM Max added Wyeth’s cough-cold offerings

BY Michael Johnsen

MADISON, N.J. Wyeth Consumer Healthcare recently added Robitussin Cough & Chest Congestion DM Max to its stable of cough-cold offerings. The new medication features twice as much guaifenesin—200 mg—as is in its Robitussin Cough & Chest Congestion DM SKU, as well as 10 mg of dextromethorphan, a cough suppressant.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Sun subsidiary extends tender offer to buy remaining shares of Taro

BY Alaric DeArment

MUMBAI, India A subsidiary of Sun Pharmaceutical Industries has extended the expiration date of the tender offer to purchase all outstanding ordinary shares of Taro Pharmaceutical Industries.

Alkaloida Chemical Company Exclusive Group said the offer would expire Dec. 19 at 5 p.m. Alkaloida extended the tender offer to comply with a continuing order issued by the Supreme Court of Israel that temporarily prohibited closing the offer until the court issued a decision on the appeal of litigation against Alkaloida by Taro.

The court will hear arguments regarding the appeal on Dec. 8. If the temporary order remains in effect on Dec. 19, Sun will further extended the offer.

India-based Sun announced its offer to buy Israel-based Taro on June 30.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?